- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on BRAFV600E Melanoma Patients in United States
Total 3123 results
-
University of California, San FranciscoGlaxoSmithKlineTerminatedBRAFV600E Melanoma PatientsUnited States
-
University of UtahWithdrawn
-
Hoffmann-La RocheTerminatedAdvanced BRAFV600 Wild-type MelanomaUnited States, Korea, Republic of, Australia, Belgium, France, Russian Federation, Italy, Netherlands, Spain, United Kingdom, Brazil, Poland, Germany, Greece, Hungary
-
University of UtahCompletedPatients at Risk for MelanomaUnited States
-
EarlySense Ltd.WithdrawnPost Operative Patient | Patients Requiring PCA | Respiratory Patients | Patients in Risk of FallUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedEvaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk AssessCancer | Cancer Screening Patients | Patient VolunteersUnited States
-
Johns Hopkins UniversityWithdrawnEngagement, Patient | Utilization, Health Care | No-Show PatientsUnited States
-
Yorkshire Ambulance Service NHS TrustUnknownPharmacist-Patient Relations | Fall PatientsUnited Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteTurnstone Biologics, Corp.RecruitingMetastatic Melanoma | Conjunctival Melanoma | Ocular Melanoma | Unresectable Melanoma | Uveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Iris Melanoma | Acral Melanoma | Non-Cutaneous MelanomaUnited States
-
National Cancer Institute (NCI)CompletedMelanoma | Malignant Melanoma | Melanoma, Experimental | Experimental MelanomasUnited States
-
University of VirginiaRecruitingResident Education, Patient Communication, Breaking Bad News to Patients Remotely, TelemedicineUnited States
-
Dana-Farber Cancer InstituteNovartisCompletedMucosal Melanoma | Acral/Lentiginous Melanoma | Chronically Sun Damaged MelanomasUnited States
-
Viewpoint Molecular TargetingMayo ClinicCompletedMelanoma (Skin) | Melanoma Stage IV | Melanoma, Uveal | Melanoma, MucosalUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Uveal Melanoma | Metastatic Ocular MelanomaUnited States
-
Dana-Farber Cancer InstitutePartner Therapeutics (PTx)WithdrawnMetastatic Melanoma | Unresectable Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
MorphotekTerminatedMelanoma | Metastatic Melanoma | Advanced Melanoma | Malignant Metastatic MelanomaUnited States
-
University of California, IrvinePfizerCompletedMelanoma | Malignant Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IA Melanoma | Stage IB Melanoma | Stage IIA MelanomaUnited States
-
University of California, IrvineGlaxoSmithKlineCompletedUnresectable Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Kartos Therapeutics, Inc.GlaxoSmithKlineCompletedMelanoma | Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, Australia
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IIA MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedStage IV Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IIA MelanomaUnited States
-
Dana-Farber Cancer InstituteAstraZenecaWithdrawnUveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Recurrent Metastatic MelanomaUnited States
-
James Isaacs, MDNot yet recruitingStage IIIB Melanoma | Stage IIIC Melanoma | Stage IIID MelanomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineCompletedUnresectable Melanoma | Stage IV Melanoma | Stage III Melanoma | BRAF Mutant MelanomaUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); Genzyme, a Sanofi CompanyWithdrawnStage IIB Melanoma | Stage IIC Melanoma | Stage IB Melanoma | Stage IIA MelanomaUnited States
-
Yana NajjarBristol-Myers Squibb; PfizerActive, not recruitingUnresectable Melanoma | Advanced MelanomaUnited States
-
Ichor Medical Systems IncorporatedMemorial Sloan Kettering Cancer CenterCompletedIntraocular Melanoma | Melanoma (Skin)United States
-
National Cancer Institute (NCI)CompletedStage IV Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Extraocular Extension Melanoma | Stage IIB Melanoma | Stage IIC MelanomaUnited States
-
National Cancer Institute (NCI)WithdrawnStage IV Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
San Diego Pacific Oncology & Hematology AssociatesUnknownIntraocular MelanomaUnited States
-
Mohammed M MilhemGenentech, Inc.TerminatedMelanoma | Metastatic Melanoma | BRAF-mutated Metastatic Melanoma | V600EBRAF-mutated Metastatic MelanomaUnited States
-
Jonsson Comprehensive Cancer CenterCompletedOcular Melanoma | Uveal Melanoma | Choroidal MelanomaUnited States
-
University of Colorado, DenverMerck Sharp & Dohme LLCActive, not recruitingStage IV Melanoma | Advanced Melanoma | Stage III MelanomaUnited States
-
Elizabeth DavisBristol-Myers SquibbTerminatedMetastatic Melanoma | Advanced Melanoma | Metastatic Melanoma Stratified by MHC-II ExpressionUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
Craig L Slingluff, JrUniversity of VirginiaCompletedMelanoma | Metastatic Melanoma | Mucosal MelanomaUnited States
-
Craig L Slingluff, JrCelldex TherapeuticsActive, not recruitingMelanoma | Ocular Melanoma | Uveal MelanomaUnited States
-
Ludwig Institute for Cancer ResearchUniversity of Chicago; University of Pittsburgh; Life Science PharmaceuticalsCompletedPhase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic MelanomaMetastatic Melanoma | Cutaneous MelanomaUnited States
-
Jonsson Comprehensive Cancer CenterCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Stage IIIc MelanomaUnited States
-
National Cancer Institute (NCI)CompletedSorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaMelanoma | Recurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma (Locally Advanced) | Stage IIC Melanoma (Locally Advanced) | Stage IV Melanoma (Limited, Resectable)United States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbWithdrawnMelanoma Stage IV | Melanoma Stage IIIUnited States
-
National Cancer Institute (NCI)TerminatedMelanoma | Malignant Melanoma | Melanoma, ExperimentalUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Mucosal MelanomaUnited States